STOCK TITAN

Freeline Therapeutics Holdings plc - $FRLN STOCK NEWS

Welcome to our dedicated page for Freeline Therapeutics Holdings plc news (Ticker: $FRLN), a resource for investors and traders seeking the latest updates and insights on Freeline Therapeutics Holdings plc stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Freeline Therapeutics Holdings plc's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Freeline Therapeutics Holdings plc's position in the market.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.46%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.29%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.29%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.65%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.65%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.39%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.39%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.25%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.71%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.35%
Tags
conferences
Freeline Therapeutics Holdings plc

Nasdaq:FRLN

FRLN Rankings

FRLN Stock Data

28.24M
26.80M
1.1%
45.88%
0.55%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United Kingdom
Stevenage

About FRLN

freeline is a biopharmaceutical company focused on the development and commercialisation of gene therapies for bleeding and other debilitating disorders based on a next-generation aav gene therapy platform developed by amit nathwani, professor of haematology at ucl and cso of freeline therapeutics http://www.freelinetx.com